Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$180M |
| 2 |
BHI
Baker Hughes
BHI
|
+$173M |
| 3 |
Dominion Energy
D
|
+$161M |
| 4 |
Kinder Morgan
KMI
|
+$155M |
| 5 |
Marathon Petroleum
MPC
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$177M |
| 2 |
SLB Ltd
SLB
|
+$121M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$119M |
| 4 |
PepsiCo
PEP
|
+$110M |
| 5 |
Mastercard
MA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.14% |
| 2 | Healthcare | 12.64% |
| 3 | Financials | 8.59% |
| 4 | Utilities | 7.75% |
| 5 | Technology | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Copart
CPRT
$30.8B
| $9.28M | 0.02% |
2,370,720
+718,064
| +43% | +$3.06M |
|
902
Eaton
ETN
$159B
| $9.28M | 0.02% |
146,391
-223,321
| -60% | -$15.8M |
|
903
Rithm Capital
RITM
$5.72B
| $9.28M | 0.02% |
795,664
+504,224
| +173% | +$6.27M |
|
904
Crocs
CROX
$6.03B
| $9.26M | 0.02% |
+736,233
| New | +$11M |
|
905
Golar LNG
GLNG
$5.25B
| $9.26M | 0.02% |
139,452
-56,710
| -29% | -$3.59M |
|
906
Pacific Biosciences
PACB
$398M
| $9.24M | 0.02% |
1,882,280
-1,006,444
| -35% | -$5.26M |
|
907
Kosmos Energy
KOS
$1.7B
| $9.23M | 0.02% |
927,238
+791,740
| +584% | +$7.93M |
|
|
MYCC
908
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $9.21M | 0.02% |
464,539
-814,735
| -64% | -$14.6M |
|
909
Invesco QQQ Trust
QQQ
$483B
| $9.21M | 0.02% |
93,201
+70,096
| +303% | +$6.83M |
|
910
CALL
Apple
AAPL
$4.53T
| $9.18M | 0.02% |
364,400
+272,000
| +294% | +$6.68M |
|
|
NUVA
911
DELISTED
NuVasive, Inc.
NUVA
| $9.18M | 0.02% |
263,138
-434,416
| -62% | -$15.5M |
|
912
Old Republic International
ORI
$10.1B
| $9.17M | 0.02% |
641,876
+428,035
| +200% | +$6.54M |
|
913
Progressive
PGR
$130B
| $9.15M | 0.02% |
362,108
-450,582
| -55% | -$11.1M |
|
914
Methode Electronics
MEI
$498M
| $9.12M | 0.02% |
247,403
+235,391
| +1,960% | +$8.35M |
|
915
CALL
Merck
MRK
$372B
| $9.12M | 0.02% |
161,182
+149,444
| +1,273% | +$8.39M |
|
|
BBT
916
Beacon Financial Corp
BBT
$2.65B
| $9.11M | 0.02% |
387,875
+12,153
| +3% | +$292K |
|
|
AVDL
917
DELISTED
Avadel Pharmaceuticals
AVDL
| $9.08M | 0.02% |
634,217
-153,618
| -19% | -$2.21M |
|
|
PCP
918
DELISTED
PRECISION CASTPARTS CORP
PCP
| $9.07M | 0.02% |
38,300
-116,090
| -75% | -$28.2M |
|
|
VXX
919
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $9.07M | 0.02% |
18,184
+5,980
| +49% | +$2.77M |
|
|
WX
920
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $9.04M | 0.02% |
258,283
+166,109
| +180% | +$5.69M |
|
|
TMHC
921
DELISTED
Taylor Morrison
TMHC
| $9.04M | 0.02% |
557,152
+131,603
| +31% | +$2.56M |
|
|
WCN
922
Waste Connections
WCN
$42.5B
| $9.03M | 0.02% |
279,203
-230,965
| -45% | -$7.49M |
|
923
CALL
GE Aerospace
GE
$355B
| $8.97M | 0.02% |
+73,032
| New | +$9.1M |
|
924
Lincoln Electric
LECO
$15.4B
| $8.96M | 0.02% |
129,537
+40,184
| +45% | +$2.8M |
|
|
ATHN
925
DELISTED
Athenahealth, Inc.
ATHN
| $8.94M | 0.02% |
67,863
-15,765
| -19% | -$2.08M |
|
Similar funds
Israel Englander's Q3 2014 Portfolio in Review
As of Q3 2014, Israel Englander held 4,400 positions worth $39.5B, up 9.5% from $36.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander deployed $4.94B of net new capital in Q3 2014, opening 1,066 new positions and adding to 1,336 existing holdings. Its largest new stake was St Jude Medical: 1,407,737 shares worth $84.6M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was SLB Ltd, an estimated $121M trimmed.
- Israel Englander's largest Q3 2014 buy was St Jude Medical: 1,407,737 shares worth $84.6M.
- Israel Englander added most to Marathon Oil Corporation in Q3 2014, an estimated $180M increase.
- Israel Englander's biggest Q3 2014 reduction was SLB Ltd, cutting an estimated $121M.
- Israel Englander fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 11% of its $39.5B portfolio in Q3 2014.
- Israel Englander opened 1,066 new positions and closed 749 in Q3 2014.
- Israel Englander's portfolio value rose 9.5% quarter-over-quarter to $39.5B.
Based on Millennium Management's 13F filing for Q3 2014, filed 14 Nov 2014.